Equillium, Inc. (EQ)
About Equillium, Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2024
- $41.1M
- Net income
- -$22.4M
- Total assets
- $31.9M
- Market cap
- $157.4M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $157.4M
- Dividend yield
- 223.58%
- Shares outstanding
- 128.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 12, 2018
Equillium, Inc. (EQ) Stock Price
- Reported a net loss of $22.4M in FY2024.
- Trading 62% below its 52-week high.
- Pays a dividend yielding about 223.58% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Equillium, Inc..
Write a review
News about Equillium, Inc.
News & sentiment via Polygon.io
Equillium, Inc.: frequently asked questions
Is Equillium, Inc. an American company?
Equillium, Inc. is a US-based company headquartered in La Jolla, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Equillium, Inc. headquartered?
Equillium, Inc. is headquartered in La Jolla, California, United States.
Is Equillium, Inc. publicly traded?
Yes — Equillium, Inc. is a publicly traded company. Its stock trades under the ticker symbol EQ on the NASDAQ.
What does Equillium, Inc. do?
Equillium, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
